Agilent Technologies Inc
NYSE: A · HEALTHCARE · DIAGNOSTICS & RESEARCH
Updated 2026-06-05
Agilent Technologies Inc (A) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $4.97B | $3.31B | 53.45% | 9.33% | 66.50% |
| 2007 | $5.42B | $638.00M | 54.78% | 10.77% | 11.77% |
| 2008 | $5.77B | $693.00M | 55.35% | 13.77% | 12.00% |
| 2009 | $4.48B | $-31.00M | 51.15% | 1.05% | -0.69% |
| 2010 | $5.44B | $684.00M | 53.82% | 10.40% | 12.56% |
| 2011 | $6.62B | $1.01B | 53.35% | 16.19% | 15.30% |
| 2012 | $6.86B | $1.15B | 52.55% | 16.32% | 16.81% |
| 2013 | $3.89B | $724.00M | 48.97% | 9.91% | 18.59% |
| 2014 | $4.05B | $549.00M | 48.81% | 10.35% | 13.56% |
| 2015 | $4.04B | $401.00M | 50.54% | 12.93% | 9.93% |
| 2016 | $4.20B | $460.00M | 52.28% | 14.64% | 10.95% |
| 2017 | $4.47B | $684.00M | 53.87% | 18.81% | 15.30% |
| 2018 | $4.91B | $316.00M | 54.68% | 18.40% | 6.43% |
| 2019 | $5.16B | $1.07B | 54.33% | 18.23% | 20.74% |
| 2020 | $5.34B | $719.00M | 53.14% | 15.85% | 13.47% |
| 2021 | $6.32B | $1.21B | 53.92% | 21.32% | 19.15% |
| 2022 | $6.85B | $1.25B | 54.35% | 23.63% | 18.31% |
| 2023 | $6.83B | $1.24B | 50.71% | 19.76% | 18.15% |
| 2024 | $6.51B | $1.29B | 54.30% | 22.86% | 19.80% |
| 2025 | $6.95B | $1.30B | 52.43% | 21.29% | 18.75% |
Frequently asked questions
What is Agilent Technologies Inc's revenue?
Agilent Technologies Inc's trailing twelve-month revenue is $7.23B, and consensus projects about $9.75B by 2030. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is A?
In its most recent fiscal year, A ran a gross margin of 52.43%, an operating margin of 21.29%, and a net margin of 18.75%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does A generate?
A produced $1.15B in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is A's balance sheet healthy?
A holds $1.79B in cash and equivalents against $3.05B in long-term debt, on $6.74B of shareholder equity. That debt is best read against the cash flow the business throws off each year.